Principal Financial Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,425
| Closed | -$37.8K | – | 2243 |
|
|
2024
Q2 | $37.8K | Sell |
11,425
-13,949
| -55% | -$46.2K | ﹤0.01% | 2307 |
|
|
2024
Q1 | $103K | Sell |
25,374
-2,088
| -8% | -$8.44K | ﹤0.01% | 2274 |
|
|
2023
Q4 | $83.8K | Sell |
27,462
-2,930
| -10% | -$8.94K | ﹤0.01% | 2288 |
|
|
2023
Q3 | $91.2K | Buy |
30,392
+4,574
| +18% | +$13.7K | ﹤0.01% | 2297 |
|
|
2023
Q2 | $96.6K | Buy |
25,818
+3,626
| +16% | +$13.6K | ﹤0.01% | 2294 |
|
|
2023
Q1 | $74.3K | Buy |
22,192
+2,644
| +14% | +$8.86K | ﹤0.01% | 2335 |
|
|
2022
Q4 | $94K | Buy |
19,548
+2,041
| +12% | +$9.82K | ﹤0.01% | 2299 |
|
|
2022
Q3 | $100K | Buy |
17,507
+4,181
| +31% | +$23.9K | ﹤0.01% | 2334 |
|
|
2022
Q2 | $94K | Buy |
+13,326
| New | +$94K | ﹤0.01% | 2399 |
|
|
2021
Q4 | – | Sell |
-6,080
| Closed | -$213K | – | 2539 |
|
|
2021
Q3 | $213K | Buy |
+6,080
| New | +$213K | ﹤0.01% | 2415 |
|